Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease

BACKGROUND: Under the Food and Drug Administration’s drug development tool qualification program, fibrinogen is the first biomarker drug development tool used in chronic obstructive pulmonary disease (COPD). However, the correlation between fibrinogen and exacerbations among Korean patients with COP...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Kim, Tae Hoon, Oh, Dong Kyu, Oh, Yeon-Mok, Lee, Sei Won, Do Lee, Sang, Lee, Jae Seung
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196189/
https://ncbi.nlm.nih.gov/pubmed/30416773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.08.52
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky